Published in Vopr Virusol on August 21, 2012
DNA-polycation complexes: effect of polycation structure on physico-chemical and biological properties. J Biotechnol (2006) 0.94
Amyloidogenic peptide homologous to beta-domain region of alpha-lactalbumin. Dokl Biochem Biophys (2007) 0.89
Plant-produced recombinant influenza vaccine based on virus-like HBc particles carrying an extracellular domain of M2 protein. Biochemistry (Mosc) (2012) 0.88
Vaccine potential of influenza vectors expressing Mycobacterium tuberculosis ESAT-6 protein. Tuberculosis (Edinb) (2006) 0.84
[Analysis of pandemic influenza in Russia as a part of the global process based on data of an influenza monitoring reference center]. Zh Mikrobiol Epidemiol Immunobiol (2011) 0.83
Effect of 6-azacytidine on the course of experimental adenoviral infection in newborn Syrian hamsters. J Chemother (2007) 0.82
Amplification of DNA sequences of Epstein-Barr and human immunodeficiency viruses using DNA-polymerase from Thermus thermophilus. Mol Cell Probes (1990) 0.82
Atomic force microscopy study of peptides homologous to beta-domain of alpha-lactalbumins. Protein Pept Lett (2007) 0.81
[The 2009 pandemic influenza in Russia. I. Diagnosis and molecular biological characteristics of the virus]. Vopr Virusol (2011) 0.81
[Cowpea mosaic virus chimeric particles bearing ectodomain of matrix protein 2 (M2E) of influenza A virus: production and characteristics]. Mol Biol (Mosk) (2009) 0.81
[Antiviral activity of several vasodilator agents]. Biull Eksp Biol Med (1996) 0.81
DNA sequencing with thermostable Tet DNA polymerase from Thermus thermophilus. Nucleic Acids Res (1989) 0.80
Recombinant influenza vaccines. Acta Naturae (2012) 0.80
The efficacy of cell therapy in the treatment of patients with trophic venous ulcers of the lower limbs. Angiol Sosud Khir (2007) 0.79
[In vitro and in vivo efficacy of Ingavirin against strains of pandemic influenza virus A(H1N1/09)v]. Zh Mikrobiol Epidemiol Immunobiol (2011) 0.79
[Secondary structure of the M2 protein of influenza type A virus and its role in forming resistance to rimantadine and deitiforin]. Mol Biol (Mosk) (1995) 0.79
[Therapeutic efficacy of Ingavirin, a new domestic formulation against influenza A virus (H3N2)]. Antibiot Khimioter (2008) 0.78
Role of the C-terminal fragment of human transthyretin in abnormal fibrillogenesis. Biochemistry (Mosc) (2006) 0.78
[Universal diagnostic oligonucleotide microarray for subtyping of human and animal influenza A viruses]. Vopr Virusol (2014) 0.78
[Molecular characteristic of influenza virus A H5N1 Strains isolated from poultry in Kurgan Region in 2005]. Mol Biol (Mosk) (2008) 0.78
[Activation of free radicals reaction and changes in the state of antioxidant protection in blood in toxic experimental influenza infection]. Biull Eksp Biol Med (1992) 0.78
[In vivo efficacy of Ingavirin against pandemic A (H1N1/09)v influenza virus]. Antibiot Khimioter (2010) 0.78
[Effect of the antiviral drug Ingaviruin on intracellular transformations and import into the nucleus of influenza A virus nucleocapsid protein]. Vopr Virusol (2011) 0.78
Development of Recombinant Vaccine against A(H1N1) 2009 Influenza Based on Virus-like Nanoparticles Carrying the Extracellular Domain of M2 Protein. Acta Naturae (2010) 0.77
[In vitro investigation of the antiviral activity of Ingavirin against human metapneumovirus]. Vopr Virusol (2012) 0.77
[Study of tolerability and reactogenicity of pandemic vaccines against influenza type A/H1N1]. Zh Mikrobiol Epidemiol Immunobiol (2010) 0.77
[Protective activity of Ingavirin in experimental lethal influenza due to pandemic influenza virus A (H1N1)v in albino mice]. Antibiot Khimioter (2010) 0.77
[Antiviral activity of Ingavirin in experimental lethal influenza due to influenza virus B in albino mice]. Antibiot Khimioter (2010) 0.77
[Experimental study of Ingavirin antiviral activity against human adenovirus]. Antibiot Khimioter (2010) 0.77
[Effect of a combination of glutamyl-tryptophan and glycyrrhizic acid on the course of acute infection caused by influenza (H3H2) virus in mice]. Vopr Virusol (2012) 0.77
[In vitro and in vivo effects of ingavirin on the ultrastructure and infectivity of influenza virus]. Vopr Virusol (2011) 0.77
[In vitro efficacy of ingavirin against the Mexican pandemic subtype H1N1 of influenza A virus, strains A/California/04/2009 and A/California/07/2009]. Antibiot Khimioter (2009) 0.77
[Use of cyto-differentiating agents in oncology]. Vopr Onkol (2006) 0.77
Fatty acid acylated antibodies against virus suppress its reproduction in cells. FEBS Lett (1989) 0.77
Direct antiviral effect of cycloferon (10-carboxymethyl-9-acridanone) against adenovirus type 6 in vitro. Antiviral Res (2003) 0.77
[Effect of different water-soluble forms of the fullerene C60 on the metabolic activity and ultra-structure of cells in culture]. Biofizika (2012) 0.77
[Investigation of prophylactic activity of Ingavirin, a new Russian drug, against grippe A virus (H3N2)]. Antibiot Khimioter (2008) 0.76
Insulin fibrillogenesis in vitro. Dokl Biochem Biophys (2008) 0.76
[Reconstruction of autonomic genetic and protein-synthesizing systems from viral RNA and isolated mitochondria]. Dokl Akad Nauk SSSR (1971) 0.76
[Experimental investigation of Ingavirin antiviral activity against human parainfluenza virus]. Antibiot Khimioter (2010) 0.76
[The structural and functional analysis of the biological activity of acridine derivatives]. Vestn Ross Akad Med Nauk (2004) 0.76
[Universal influenza vaccines: developments, prospects for use]. Vopr Virusol (2012) 0.76
[Development of the anti-influenza H5N1 vaccines worldwide and in Russia]. Zh Mikrobiol Epidemiol Immunobiol (2006) 0.76
[Antiviral action of some antioxidants/antihypoxants and their combinations with remantadine against human influenza A(H3N2) virus studied in in vitro models]. Eksp Klin Farmakol (2007) 0.75
[Prophylactic and therapeutic efficacies of Ingavirin, a novel Russian chemotherapeutic, with respect to influenza pathogen A (H5N1)]. Antibiot Khimioter (2010) 0.75
[Influence of rimantadine, ribavirine and triazavirine on influenza A virus replication in human monolayer and lymphoblastoid cell lines]. Antibiot Khimioter (2011) 0.75
[Antiviral effect of Ingavirin against seasonal influenza virus A/H1N1 in MDCK cell culture]. Antibiot Khimioter (2009) 0.75
[Protective effect of cycloferon in experimental influenza]. Vopr Virusol (2001) 0.75
[The anti-viral activity of the complex glycyrrhizic acid-alpha-glutamyl-tryptophan against experimental lethal influenza infection in white mice caused by oseltamivir-resistant strain of the virus]. Vopr Virusol (2014) 0.75
[The International Scientific Conference on the Optimization of Influenza Control]. Vopr Virusol (1994) 0.75
[Influenza: current status and epidemiologic situation]. Vestn Ross Akad Med Nauk (1994) 0.75
[Determination of nucleotide sequences of Russian isolates of delta hepatitis virus]. Mol Gen Mikrobiol Virusol (1997) 0.75
[Effect of homologous nuclear RNA and infectious RNA of the Venezuelan equine encephalitis virus on the biosynthesis of RNA and protein in isolated rat liver mitochondria]. Biokhimiia (1974) 0.75
[Molecular mechanisms of selecting influenza virus strains by signs of drug resistance]. Dokl Akad Nauk SSSR (1991) 0.75
[Compatibility of mitochondrial ribosomes with matrix RNA of nuclear origin]. Dokl Akad Nauk SSSR (1973) 0.75
[Lymphokine-like activity in a culture of cells of the embryonal human brain and in the cerebrospinal fluid]. Fiziol Zh SSSR Im I M Sechenova (1988) 0.75
[Antiviral activity of fullerene (60)C complexed with poly(N-vinylpyrrolidone)]. Dokl Akad Nauk (1998) 0.75
[Electron transport chain in the isolated nuclei and nuclear membranes of the rat liver]. Biokhimiia (1974) 0.75
[Replication of infectious viral RNA in isolated mitochondria. 1. Penetration of vital RNA into mitochondria and its effect on mitochondrial synthesis]. Vopr Virusol (1972) 0.75
[Molecular chaperones: new proteins--new functions]. Mol Biol (Mosk) (1992) 0.75
[Clinical trial of new inactivated influenza vaccine "Grifor"]. Zh Mikrobiol Epidemiol Immunobiol (2009) 0.75
[Properties of thermostable HtpR-mutant of Escherichia coli]. Mol Gen Mikrobiol Virusol (1988) 0.75
Origin of the mitochondrial RNA of animal tissues. 2. Hybridization with nuclear DNA. Mol Biol (1974) 0.75
[Long-term carriers of genomic structures of the influenza virus in the blood leukocytes of children with congenital pathology of central nervous system]. Vestn Ross Akad Med Nauk (1994) 0.75
[Isolation of an individual mRNA from mitochondria, its reverse transcription and characteristics of the complementary DNA]. Dokl Akad Nauk SSSR (1978) 0.75
[Polyadenylic acid sequence in viral RNA]. Vopr Virusol (1976) 0.75
[Pathogenesis of severe influenza]. Vestn Ross Akad Med Nauk (1994) 0.75
[Isolation and cloning of gene for hepatitis delta antigen. The use of recombinant antigen for serodiagnosis of delta infection]. Mol Gen Mikrobiol Virusol (1998) 0.75
[The effect of oxygen free radicals on the viability of strains of Saccharomyces with various levels of expression of the metallothionein gene]. Dokl Akad Nauk SSSR (1989) 0.75
[The role of influenza virus hemagglutinin in blood anticoagulation processes]. Vopr Virusol (1997) 0.75
[Anti-HIV activity of complex isoborneol ethers]. Dokl Akad Nauk (1992) 0.75
[The molecular mechanism of the action of antiviral preparations in the adamantane series]. Vestn Ross Akad Med Nauk (1993) 0.75
[Current approaches to the treatment of severe influenza]. Vestn Ross Akad Med Nauk (1994) 0.75
[An analysis of the potential areas of recombination in the hemagglutinin genes of animal influenza viruses in relation to their adaptation to a new host--man]. Vopr Virusol (1994) 0.75
[Regulation of expression of the htpR gene in Escherichia coli]. Mol Biol (Mosk) (1987) 0.75
[Detection of nucleotide sequences specific for retroviruses in Saccharomyces cells]. Genetika (1987) 0.75
[Actinomycin D binding with the DNA of some transplantable tumors]. Dokl Akad Nauk SSSR (1971) 0.75
[Interleukin-2 and cancer immunotherapy]. Vopr Onkol (1989) 0.75
[Features of interepidemic influenza A and B viruses]. Vestn Ross Akad Med Nauk (1995) 0.75
[Polymorphism of current human influenza A and B virus population]. Vestn Ross Akad Med Nauk (1994) 0.75
[The effective use of superoxide dismutase from human erythrocytes in the late stages of experimental influenza infection]. Vopr Virusol (1992) 0.75